Andrea Jegerlehner

Author PubWeight™ 9.00^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design.	Eur J Immunol	2008	1.30
2	Critical role for activation of antigen-presenting cells in priming of cytotoxic T cell responses after vaccination with virus-like particles.	J Immunol	2002	1.10
3	Universal vaccine against influenza virus: linking TLR signaling to anti-viral protection.	Eur J Immunol	2012	1.09
4	Complement receptors regulate differentiation of bone marrow plasma cell precursors expressing transcription factors Blimp-1 and XBP-1.	J Exp Med	2005	1.04
5	Virus-like particles as carriers for T-cell epitopes: limited inhibition of T-cell priming by carrier-specific antibodies.	J Virol	2005	1.01
6	Alveolar macrophages and lung dendritic cells sense RNA and drive mucosal IgA responses.	J Immunol	2009	0.98
7	Virus-like particles as a modular system for novel vaccines.	Intervirology	2002	0.85
8	Low-affinity B cells transport viral particles from the lung to the spleen to initiate antibody responses.	Proc Natl Acad Sci U S A	2012	0.81
9	Enhanced neutralizing antibody titers and Th1 polarization from a novel Escherichia coli derived pandemic influenza vaccine.	PLoS One	2013	0.76